EUVIMEDEUVIMED entdecken
Crossref

A Randomized, Double Blind, Placebo-Controlled, Crossover Study to Evaluate the Analgesic Activity of Terminalia bellerica in Healthy Human Participants Using the Thermal Pain Model - Hot Air Pain Model

Merugu PL, Lanke VM, Gaddameedi AJ

International Journal of Drug Delivery Technology · 01.07.2026 · 16 (60s)

DOI: 10.25258/ijddt.16.60s.178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 01.07.2026. Verfasst von Merugu PL und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pain is a common and often disabling symptom associated with many medical conditions and may be triggered by external or internal stimuli. Opioids and nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used analgesics; however, their use is associated with adverse effects, necessitating the search for safer alternatives. Animal studies have demonstrated significant analgesic activity of the ethanolic and aqueous extracts of Terminalia bellerica (T. bellerica). Therefore, the present study was undertaken to evaluate the analgesic activity and safety of a standardized aqueous extract of T. bellerica in healthy volunteers using the hot-air pain model. Materials and Methods This randomized, double-blind, placebo-controlled, crossover study was conducted after obtaining informed consent and Institutional Ethics Committee approval. Twelve healthy adult participants were randomized in a double-blind manner to receive a single oral dose of either two 500-mg capsules of T. bellerica extract or identical placebo capsules. Thermal pain was assessed using a hot-air analgesiometer. Mean pain threshold and pain tolerance times were measured at baseline and 2 h after dosing. After a 2-week washout period, participants crossed over to receive the alternate treatment, and the procedure was repeated. Safety was assessed before and after the study. Data were analyzed using GraphPad Prism 7.

Results

Compared with baseline and placebo, T. bellerica significantly increased mean pain threshold time from 33.53 ± 1.53 to 38.19 ± 1.93s (p

Zitieren

APA

PL, M., VM, L., & AJ, G. (2026). A Randomized, Double Blind, Placebo-Controlled, Crossover Study to Evaluate the Analgesic Activity of Terminalia bellerica in Healthy Human Participants Using the Thermal Pain Model - Hot Air Pain Model. International Journal of Drug Delivery Technology, 16(60s). https://doi.org/10.25258/ijddt.16.60s.178

Vancouver

PL M, VM L, AJ G. A Randomized, Double Blind, Placebo-Controlled, Crossover Study to Evaluate the Analgesic Activity of Terminalia bellerica in Healthy Human Participants Using the Thermal Pain Model - Hot Air Pain Model. International Journal of Drug Delivery Technology. 2026;16(60s). doi:10.25258/ijddt.16.60s.178

BibTeX
@article{PL2026,
  author = {PL, Merugu and VM, Lanke and AJ, Gaddameedi},
  title = {A Randomized, Double Blind, Placebo-Controlled, Crossover Study to Evaluate the Analgesic Activity of Terminalia bellerica in Healthy Human Participants Using the Thermal Pain Model - Hot Air Pain Model},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {60s},
  doi = {10.25258/ijddt.16.60s.178}
}
Kostenlos starten →